On the basis of the heterogeneity in PSMA and PSA expression along prostatic tumor progression, we suggested the presence of various profiles of these prostate-associated antigens in each prostatic group (NP, BPH and PC). The gene discussed is FOLH1; the disease is prostate neoplasm.